Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Merck & Co., Inc. (MRK) had Normalized Income after Taxes of $3.20B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$16.40B |
|
$2.96B |
|
$5.55B |
|
$10.85B |
|
$12.34B |
|
$4.07B |
|
$-645.00M |
|
$3.42B |
|
$3.63B |
|
$2.96B |
|
$2.96B |
|
$2.96B |
|
|
Normalized Income after Taxes |
$3.20B |
$4.07B |
|
-- |
|
-- |
|
2.49B |
|
-- |
|
$1.19 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|